Summary. This study investigated early alterations of glucose metabolism in idiopathic haernochromatosis. Circulating concentrations of glucose, insulin, C-peptide, glucagon, and gastric inhibitory polypeptide (GIP) were measured after a 100-g oral glucose load in 10 men with idiopathic haemochromatosis in the non-cirrhotic stage of the disease. All had normal glucose tolerance and normal body weight. Ten matched healthy subjects were studied as controls. Insulin concentrations increased to significantly higher levels in patients with idiopathic haemochromatosis than in the control subjects from 30 to 180min after the glucose load (p~<0.01), while fasting insulin concentrations were not significantly different (p> 0.05). Concentrations of glucose, glucagon, C-peptide, and GIP were not significantly different at any time (p > 0.05).
Diabetes mellitus is one of the classical clinical features in idiopathic haemochromatosis (IHC). The cause of the close association between hyperglycaemia and IHC, however, remains uncertain. Damage to pancreatic islets by iron deposits in/3 cells, genetic predisposition, and hepatic cirrhosis are thought to be the main factors causing diabetes mellitus in IHC [1] [2] [3] [4] . Diabetes mellitus and impaired glucose tolerance are also frequent features of other chronic liver diseases [5] [6] . Since insulin resistance is a major cause of impaired glucose tolerance in other chronic liver diseases [6] [7] [8] [9] , it might also be responsible for the impaired glucose tolerance associated with IHC. However, this hypothesis has not been substantiated or refuted so far. This study investigated early alterations of glucose metabolism in IHC: circulating concentrations of glucose, insulin, C-peptide, glucagon, and gastric inhibitory polypeptide (GIP) were measured following an oral glucose load in a homogeneous group of non-cirrhotic IHC patients and were compared with those of matched healthy control subjects.
Subjects and methods

Subjects
Ten men with idiopathic haemochromatosis were studied. The clinical data are shown in Tables 1 and 2 . The diagnosis was proved in all cases by: (1)histology of liver biopsy; (2)histochemical or chemical determination of iron excess in liver tissue; (3)documentation of abnormal serum concentrations of iron, transferrin, and ferfitin; (4)exclusion of other liver diseases, such as that due to alcohol. Most patients had further strong evidence of IHC by determination of HLA antigens and family history (Table 2) . In seven patients, additional biopsies of the intestinal mucosa were evaluated for iron content. Five of the seven patients had increased iron deposits in the intestinal mucosa (Table 2) . IHC patients included in the study had normal glucose tolerance, normal body weight (Broca-index + 10%), no history of increased alcohol consumption, and did not show hepatic cirrhosis. All had normal liver function as demonstrated by normal blood coagulation tests and normal serum albumin. Eight of the ten had slightly elevated levels of serum alanine aminotransferase ( Table 2 ). All IHC patients were studied before starting venesection therapy. Ten healthy male subjects were studied as controls. All subjects gave informed consent. The subjects were matched for age, height, weight, and physical activity. The physical data of the IHC patients and the matched healthy controls are shown in Table 1 . Mean values of age, weight, height, and physical activity were almost identical in both groups. Physical activity of the subjects at work and in sports was graded as 1 = low, 2 = normal, and 3 = high physical activity Family history of IHC was graded by the numbers of relatives (parents, grandparents, or siblings) with insulin-dependent diabetes, hepatic cirrhosis, or IHC. Alcohol intake was graded as 0 = no alcohol, 1 = < 20 g/day, 2 = > 20 g/day, 3 = > 60 g/day. Hepatic iron was graded according to [20] . ND = not determined
Oral glucose tolerance test
Studies were performed on recumbent subjects after an overnight fast. All had a carbohydrate intake of at least 250 g/day, abstained from alcohol for 48-72 h and were not on any drugs. An intravenous Teflon cannula was inserted in an antecubital vein. Glucose (100 g) was given orally in 400 ml water at time 0 and blood samples were taken at -10, 0, 30, 60, 90, 120, and 180 min.
Laboratory determinations
Glucose was measured by the glucose-oxidase method [10] . Concentrations of glucagon and GIP were determined by radioimmunoassay as described previously [11] [12] [13] [14] . The intra-assay variance for the radioimmunoassay of GIP was 6.2 ___ 0.9% and the interassay variance 14.1 + 1.2% (mean _+ SEM of five assays). Commercial kits were used to measure the plasma concentrations of insulin (Pharmacia, Uppsa- 
Statistical methods
The statistical significance of differences between concentrations of glucose, insulin, C-peptide, glucagon, and GIP in the two groups was calculated using Wilcoxon's test for paired values.
Results
Concentrations of glucose, insulin, C-peptide, glucagon, and GIP are shown in Table 3 . Insulin concentrations increased to significantly higher levels in IHC patients than in the healthy subjects (p< 0.0J ; Fig. 1 ). This difference was significant at all times between 30 and 180 min. In all 10 IHC patients, the maximal serum insulin concentration after glucose was higher when compared with the corresponding matched control subjects (Table 1) . Fasting insulin concentrations were not significantly different in IHC patients compared with the healthy subjects (p>0.05). Concentrations of glucose, glucagon, GIP, and C-peptide were not significantly different in IHC patients or healthy control subjects at any time (p> 0.05).
Discussion
These results show hyperinsulinaemia after oral glucose in patients with non-cirrhotic IHC compared with healthy control subjects, even though all IHC patients had normal glucose tolerance. The association of hyperinsulinaemia and normal (or impaired) glucose tolerance is often described as insulin resistance [6] [7] . Insulin resistance has been thought to occur in IHC for some time [15] , since most other chronic liver diseases also show hyperinsulinaemia and insulin resistance [5] [6] [7] . There are only a few rather inconclusive studies on insulin secretion and glucose metabolism in IHC [16] [17] . Two showed deficient or delayed insulin responses to oral glucose and failed to prove insulin resistance. In these studies, however, IHC patients were not characterized by liver biopsies or grouped according to their body weight, glucose tolerance or diabetes mellitus [16] [17] .
As iron overload in IHC may damage pancreatic a and fl cells, hepatocytes and intestinal mucosa (enteroinsulinar axis), we also measured glucagon , C-peptide, and GIP. Our results show that, in the non-cirrhotic stage of the disease, t-cell function is not impaired as shown by the normal C-peptide concentrations.
In concordance with a previous study on a-cell function in IHC [18] , concentrations of glucagon did not differ between IHC patients and healthy subjects. A study in diabetic IHC patients has shown that, in this stage of the disease, glucagon hypersecretion can be observed as in other types of diabetes [19] . Although iron deposits in the intestinal mucosa could be demonstrated in most non-cirrhotic IHC patients, the enteroinsulinar axis is unimpaired as shown by a normal increase of GIP after oral glucose.
Despite the difference of insulin concentrations between the IHC patients and the control subjects, absolute insulin concentrations were relatively low in both groups due to the fact that all subjects were relatively young men without impaired glucose tolerance and with relatively high levels of physical activity. Obesity, as a cause of hyperinsulinaemia and insulin resistance, was excluded by studying only subjects with normal body weight and by matching the IHC patients and the healthy subjects for body weight. Since/3-cell function, glucagon secretion, and the entero-insulinar axis were demonstrated to be normal, hyperinsulinaemia and the reduced insulin effect (i. e. insulin resistance) may be related to the iron accumulation in hepatocytes. Intrahepatic shunts can be excluded because none of the subjects studied had histological evidence of cirrhosis. A receptor defect or an intracellular impairment of hepatocyte function by iron overload could also produce impaired insulin extraction. As a consequence of this, hyperinsulinaemia is achieved without insulin-hypersecretion as demonstrated by the normal C-peptide levels.
These findings and their interpretation do not rule out the possibility that, as IHC progresses, pancreatic insulin secretion may also become impaired. Indeed, this is to be expected, because of the significantly higher percentage of overt diabetes in IHC patients with cirrhosis compared to patients with cirrhosis from other causes [6] . Following-up the non-cirrhotic IHC patients in the present series may show whether the diabetic tendency of IHC is ameliorated by venesection therapy.
